The following is a summary of “Efficacy and safety of first-line targeted synthetic DMARDs in rheumatoid arthritis patients with chronic kidney disease,” published in the January 2025 issue of ...

Identify triggers, recognize symptoms, and manage RA flare-ups effectively with lifestyle, medication, and support for better ...

Discover the reality behind Rheumatoid Arthritis, from its early onset potential to exercise benefits, backed by latest ...

If you’re living with rheumatoid arthritis (RA), you may know the role that chronic ... In addition to your treatment plan, they may refer you to an occupational therapist for support.

The technology was announced at the JP Morgan Healthcare Conference in San Francisco. In this project, the stakeholders aim to use a human reference genome to combine with patient data in order to try ...

This systematic review of real-world observational studies demonstrated the effectiveness of Janus kinase (JAK) inhibitors in ...

New research highlights a link between immune checkpoint inhibitors (ICIs) and an increased risk of autoimmune diseases, including rheumatoid arthritis, emphasizing the need for vigilance among ...

Although sustained remission free of disease-modifying antirheumatic drugs “does not seem attainable” for patients with ...

A study from Spain found a subcutaneous tocilizumab biosimilar to be cost-effective when treating patients with rheumatoid ...

BTIG analyst Julian Harrison has maintained their bullish stance on SYRE stock, giving a Buy rating on January 14.Invest with Confidence: ...

Five out of every 1,000 Malaysians are affected by Rheumatoid Arthritis (RA), a condition that causes chronic autoimmune joint pain, with women said to be two to three times more at risk than men.